Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2024-04-28 Interim / Quarterly Rep…
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 512.7KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 29 April 2024 from ECS Botanics Holdings Ltd providing a quarterly update for Q3 FY24 ending 31 March 2024. It includes detailed financial and operational highlights such as revenue figures, cash flow data, capital raise information, and operational progress. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for Australian listed companies to report quarterly cash flows, confirms this is a quarterly report. The document contains substantive financial data and analysis for the quarter, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2024
2024-04-28 English
H1 FY24 results webinar 11 pages 1.9MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'FY24 Half Year Results Presentation' and dated March 6, 2024. It contains detailed financial highlights for the half year ended December 31, 2023, including revenue, EBITDA, NPAT, balance sheet data, cash flow, operational highlights, strategic roadmap, and market information. The content is structured as a presentation with charts and financial metrics, focusing on the half-year financial performance and business strategy. There is no indication that this is a full annual report (10-K) or a regulatory announcement. The document is not a transcript, audit report, or legal filing. It is a detailed investor presentation of half-year financial results and strategic outlook. Therefore, the most appropriate classification is 'Interim / Quarterly Report (IR)' because it is a comprehensive financial report for a period shorter than a full fiscal year, containing substantive financial data and analysis. H1 2024
2024-03-05 English
Half Yearly Report and Accounts 31 pages 2.5MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Year Report | 31 December 2023' and contains detailed financial statements such as Consolidated Statement of Profit or Loss, Statement of Financial Position, and Cash Flows. It includes a Directors' Report, Auditor's Independence Declaration, and an Independent Auditor's Review Report. The content covers financial results, operational highlights, strategic focus, and corporate activities for the half-year period ending 31 December 2023. The length is substantial (15,000 characters) and contains actual financial data and analysis, not just an announcement or summary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year with substantive financial data and analysis. H1 2024
2024-02-27 English
ECS achieves profitable half year results 4 pages 391.9KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 28 February 2024 from ECS Botanics Holdings Ltd reporting financial results for the six months ended 31 December 2023 (H1 FY24). It includes detailed financial highlights such as NPAT, EBITDA, revenue, cash flow, and operational updates including contract agreements, cultivation expansion, and R&D results. The document contains substantive financial data and analysis for a half-year period, indicating it is a comprehensive interim financial report rather than a brief earnings release or a simple announcement. The length of the document (over 11,000 characters) and the detailed financial and operational information confirm it is an Interim / Quarterly Report. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2024
2024-02-27 English
Application for quotation of securities - ECS 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It details the number and type of securities to be quoted, issue dates, and other issuance details. This type of document is a formal announcement related to the listing or quotation of new securities following a prior announcement (Appendix 3B). It is not a financial report, earnings release, or management discussion. It is specifically an announcement about capital changes related to securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the actual announcement, not just a brief notice or report publication announcement.
2024-02-27 English
Notification regarding unquoted securities - ECS 6 pages 19.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted options by ECS Botanics Holdings Ltd. It includes specifics such as the number of securities issued, issue date, and terms of the securities. The document is a formal notification related to securities issuance, referencing previous announcements (Appendix 3B) and providing detailed issuance information. This fits the category of a Share Issue/Capital Change announcement rather than a full financial report or other types of filings. The document length and content confirm it is not merely an announcement of a report but a substantive notification of capital changes.
2024-02-27 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.